Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.
Ye Y, Kuang X, Xie Z, Liang L, Zhang Z, Zhang Y, Ma F, Gao Q, Chang R, Lee HH, Zhao S, Su J, Li H, Peng J, Chen H, Yin M, Peng C, Yang N, Wang J, Liu J, Liu H, Han L, Chen X.
Ye Y, et al. Among authors: wang j.
Genome Med. 2020 Sep 28;12(1):83. doi: 10.1186/s13073-020-00780-z.
Genome Med. 2020.
PMID: 32988398
Free PMC article.